Owens & Minor, Inc. (NYSE:OMI) Stock Position Lessened by Renaissance Technologies LLC

Renaissance Technologies LLC lessened its holdings in shares of Owens & Minor, Inc. (NYSE:OMI - Free Report) by 7.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,078,100 shares of the company's stock after selling 90,000 shares during the period. Renaissance Technologies LLC owned approximately 1.40% of Owens & Minor worth $14,091,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Blue Trust Inc. grew its holdings in Owens & Minor by 57.4% in the 4th quarter. Blue Trust Inc. now owns 4,387 shares of the company's stock valued at $57,000 after buying an additional 1,600 shares during the period. KBC Group NV raised its stake in Owens & Minor by 98.2% during the fourth quarter. KBC Group NV now owns 4,434 shares of the company's stock worth $58,000 after purchasing an additional 2,197 shares during the period. Inspire Advisors LLC boosted its holdings in shares of Owens & Minor by 11.2% in the 4th quarter. Inspire Advisors LLC now owns 15,350 shares of the company's stock valued at $201,000 after purchasing an additional 1,548 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of Owens & Minor during the 4th quarter worth $256,000. Finally, Wealthfront Advisers LLC purchased a new position in shares of Owens & Minor in the 4th quarter worth $257,000. Institutional investors and hedge funds own 98.04% of the company's stock.

Owens & Minor Stock Up 2.6 %

NYSE OMI traded up $0.18 during mid-day trading on Friday, reaching $6.95. 1,174,379 shares of the company's stock traded hands, compared to its average volume of 1,098,567. The company has a fifty day simple moving average of $8.26 and a 200-day simple moving average of $11.51. Owens & Minor, Inc. has a 1-year low of $6.07 and a 1-year high of $25.82. The company has a market cap of $536.54 million, a price-to-earnings ratio of -10.68, a P/E/G ratio of 0.20 and a beta of 1.02. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its quarterly earnings results on Friday, February 28th. The company reported $0.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.02. The firm had revenue of $2.70 billion for the quarter, compared to analysts' expectations of $2.68 billion. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm's quarterly revenue was up 1.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.69 earnings per share. As a group, equities research analysts expect that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor declared that its board has approved a stock repurchase program on Friday, February 28th that permits the company to buyback $100.00 million in shares. This buyback authorization permits the company to buy up to 13.6% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's board believes its shares are undervalued.

Insider Transactions at Owens & Minor

In related news, major shareholder Coliseum Capital Management, L acquired 225,000 shares of Owens & Minor stock in a transaction that occurred on Wednesday, April 9th. The stock was acquired at an average price of $7.39 per share, for a total transaction of $1,662,750.00. Following the transaction, the insider now directly owns 11,482,955 shares of the company's stock, valued at $84,859,037.45. This trade represents a 2.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last three months, insiders have acquired 2,718,412 shares of company stock worth $24,495,308. 3.69% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities analysts have recently commented on the company. UBS Group cut their price objective on Owens & Minor from $25.00 to $13.00 and set a "buy" rating on the stock in a report on Thursday, February 13th. Citigroup reduced their target price on shares of Owens & Minor from $13.00 to $11.00 and set a "buy" rating on the stock in a report on Thursday. Robert W. Baird increased their price target on Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a report on Monday, March 3rd. Finally, JPMorgan Chase & Co. reduced their price objective on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating on the stock in a research note on Monday, March 10th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $12.50.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.